COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.
Stay current on PCCA news and events, market trends, and all things compounding!
We’re reviewing the distinctions between SuspendIt and SuspendIt Anhydrous, as well as how revisions to USP Chapter 795 will guide beyond use dates (BUDs) for aqueous and nonaqueous oral dosage forms.
PCCA Director of Formulations Melissa Merrell Rhoads, PharmD, offers insights on working with SuspendIt Anhydrous in oral suspension formulations